| MuPeXI: prediction of neo-epitopes from tumor sequencing data AM Bjerregaard, M Nielsen, SR Hadrup, Z Szallasi, AC Eklund Cancer Immunology, Immunotherapy 66, 1123-1130, 2017 | 200 | 2017 |
| An analysis of natural T cell responses to predicted tumor neoepitopes AM Bjerregaard, M Nielsen, V Jurtz, CM Barra, SR Hadrup, Z Szallasi, ... Frontiers in immunology 8, 1566, 2017 | 103 | 2017 |
| CD8+ T cells from patients with narcolepsy and healthy controls recognize hypocretin neuron-specific antigens NW Pedersen, A Holm, NP Kristensen, AM Bjerregaard, AK Bentzen, ... Nature communications 10 (1), 837, 2019 | 96 | 2019 |
| Human endogenous retroviruses and their implication for immunotherapeutics of cancer AS Attermann, AM Bjerregaard, SK Saini, K Grønbæk, SR Hadrup Annals of Oncology 29 (11), 2183-2191, 2018 | 89 | 2018 |
| Neoantigen-reactive CD8+ T cells affect clinical outcome of adoptive transfer with tumor-infiltrating lymphocytes in melanoma NP Kristensen, C Heeke, SA Tvingsholm, A Borch, A Draghi, ... The Journal of Clinical Investigation, 2021 | 72* | 2021 |
| Human endogenous retroviruses form a reservoir of T cell targets in hematological cancers SK Saini, AD Ørskov, AM Bjerregaard, A Unnikrishnan, ... Nature communications 11 (1), 1-14, 2020 | 64 | 2020 |
| Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinoma JS Holm, SA Funt, A Borch, KK Munk, AM Bjerregaard, JL Reading, ... Nature Communications 13 (1), 1-17, 2022 | 46 | 2022 |
| Tumor-Infiltrating T Cells From Clear Cell Renal Cell Carcinoma Patients Recognize Neoepitopes Derived From Point and Frameshift Mutations UK Hansen, S Ramskov, AM Bjerregaard, A Borch, R Andersen, A Draghi, ... Frontiers in immunology 11, 373, 2020 | 30 | 2020 |
| Prediction of neoepitopes from murine sequencing data AM Bjerregaard, TK Pedersen, AM Marquard, SR Hadrup Cancer Immunology, Immunotherapy 68 (1), 159-161, 2019 | 7 | 2019 |
| Identification of Hypothalamic Glucoregulatory Neurons That Sense and Respond to Changes in Glycemia JD Deem, D Tingley, AM Bjerregaard, A Secher, O Chan, C Uzo, ... Diabetes, db230139, 2023 | 3 | 2023 |
| Neoepitope load, T cell signatures and PD-L2 as combined biomarker strategy for response to checkpoint inhibition immunotherapy A Borch, AM Bjerregaard, V Araujo Barbosa de Lima, O Østrup, CW Yde, ... Frontiers in genetics 14, 1058605, 2023 | 2 | 2023 |
| Neoantigen reactive T cells correlate with the low mutational burden in hematological malignancies SK Saini, S Holmberg-Thydén, AM Bjerregaard, A Unnikrishnan, ... Leukemia 36 (11), 2734-2738, 2022 | 2 | 2022 |
| HLA-C restricted neoepitopes contribute significantly to the immune recognition of cancer S Ramskov, KU Hansen, KS Saini, T Sturm, A Borch, AM Bjerregaard, ... European Journal of Immunology 49 (Suppl. 3 SI), 387-387, 2019 | 1 | 2019 |
| A Lipopolysaccharide Mouse Model Mirrors Neuroinflammatory Transcriptional Signatures of Human AD, and the Glucagon-Like Peptide-1 Receptor Agonist Semaglutide Attenuates … MQ Ludwig, DM Belmont-Rausch, A Secher, MA Bentsen, SN Hansen, ... Neurology 100 (17 Supplement 2), 2023 | | 2023 |
| How cancer specific T-cell recognition and functionality is affected by combination of radio-and immunotherapeutic strategies TS Meldgaard, LR Petersen, TK Pedersen, A Bjerregaard, AM Marquard, ... European Journal of Cancer 92, S21, 2018 | | 2018 |
| Surface accumulation of receptor tyrosine kinases upon treatment with tyrosine kinase inhibitors and resulting enhancement of activity upon treatment cessation AM Bjerregaard, MV Grandal, C Frohlich, T Lindsted, C Egebjerg, ... Cancer Research 75 (15_Supplement), 5455-5455, 2015 | | 2015 |
Aron Charles EklundClinical Microbiomics A/SVerified email at clinical-microbiomics.com
